Click to Share
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
News By Tag
Biotech Remove
Related Tags

December 2015
We Tu Mo Su Sa Fr Th
2 1
November 2015
30 29 28 27 26

biotech Press Releases

  + XML/RSS  

By Merit Harbor Group
David Lopez joins Merit Harbor Group with deep M&A and consulting experience in the healthcare and healthcare technology industries.
By ImmunoReagents
Leading Life Science Reagent Manufacturer ImmunoReagents joins forces with Bioseparations Technology Innovator ProteoVec to transform antibody purification.
By Polyplus-transfection
Les responsables politiques devraient s’occuper de balayer devant leur propre porte et se concentrer sur leurs dossiers importants, plutôt que de critiquer la prime d’engagement offerte à Olivier Brandicourt par Sanofi, selon Mark Bloomfield,...
By Polyplus-transfection
The political establishment needs to concentrate on cleaning up its own act and concentrating on their own critical matters, before getting involved with the golden hello offered to Olivier Brandicourt by Sanofi, says Mark Bloomfield, CEO, Polyplus.
By Spaulding Clinical Research, LLC
a full-service CRO announced today that they will be in attendance at the American Society for Clinical Pharmacology and Therapeutics’ (ASCPT) 2015 Annual Meeting.
By Helix BioMedix, Inc.
R. Stephen Beatty is appointed to Chairman of the Board of Directors
By BusinessDemographics, LLC
Pfizer Chemical R&D group of Groton CT hires Marshall Greenwood of Milton MA as Chemical Engineer thru Northeastern University's Co-op program.
By American Heritage Insurance
All businesses are at risk, particularly the small to medium size businesses who have less sophisticated security measures. They are much more vulnerable than the "big guys".
By Cadence Research & Consulting
Hall brings product access, specialty pharmacy and distribution dynamic expertise
By Theivasanthi
Superparamagnetic Plants Materials Innovations have World Record entry in LIMCA Book
By M2 Scientifics LLC
M2 Scientifics (, proudly announces the release of a new website and ordering features, resulting in an even more superior experience for the company's broad array of clients.
By Visiongain
Visiongain’s new report predicts the world stem cell technologies market will reach $7.2bn in 2014. The overall industry will earn $12bn in 2018, achieving high revenue growth from 2015 to 2025.
By Bio-En Holdings Corp
December 17, 2014 – New York – Bio-En Holdings (OTC: BENH) announces today that its common stock is set to begin trading under ticker symbol “BENH”.
By The Knowledge Group, LLC
Joseph Lenthall, Patent Attorney, Mewburn Ellis LLP to Speak at Knowledge Congress’ LIVE Webcast
By The Knowledge Group, LLC
Glyn Truscott, Senior Attorney, Carpmaels & Ransford LLP to Speak at Knowledge Congress’ LIVE Webcast
By Theravectys, Deloitte
A rewarding November for the promising French biotech: a prestigious prize & an impactful communication tool
By Advanced Cancer Therapeutics
Announces MD Anderson and UT Health Science Center San Antonio Added as Clinical Trial Sites
By NuVascular Technologies, Inc.
Medical Device Company Cited for Breakthrough Electrospinning Platform Technology, Which Has a Large Variety of Applications
By Lacerta Bio
Lacerta Bio to merge with an international Life Science advisory firm, Ventac Partners, to strengthen their position in USA.
By Molekule Consulting, Inc.
Molekule consulting, Inc. to sponsor & exhibit at the 2015 Pharma CI Europe Conference & Exhibition. Molekule President, David Alderman, to speak on key competitive intelligence topic
By NuVascular Technologies, Inc.
Textiles and healthcare converge in patented approach to create drug-loaded devices to treat an array of conditions
By Q1 Productions
Interactive Sessions to Address Prevention of Counterfeit Products, FDA Expectations, Future of Sustainability Trends
By Cambridge Healthtech Institute
Leading Pharma, Biotech and Academic Researchers Unite to Share Findings for the Role of Circulating microRNA, Exosomes and Microvesicles, Long Non-Coding RNA and Extracellular RNA in Disease
By Bionow
Bionow is delighted to be hosting the 2014 BioInfect Conference. A major one day conference looking at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance.
By Implantable Artificial Kidney Corporation (IAKC)
Dr. Ira Kurtz will advise IAKC in research & development of the IAK-1 implantable artificial kidney
By Obsidian HDS LLC
Obsidian HDS, the developer of PharmaShine ( -  an online service for the management of data on pharmaceutical and device industry payments to healthcare professionals announced today that PharmaShine now includes the Open...
By NuVascular Technologies, Inc.
NuVascular Technologies, Inc. utilizes patented electrospinning process to create new medical devices to help millions
By marcus evans
Inviting Heads, VPs, Directors, Managers, and Specialists of Labeling and Regulatory Affairs from leading pharmaceutical and biotech companies to discuss best practices for generic label documentation
By Knome
Knome, Inc. today announced that it has entered a sponsorship agreement with LabCentral to provide the knoSYS® Informatics and Genomic Interpretation System to startups operating in LabCentral’s facility in Kendall Square.
By Cambridge Healthtech Institute
Emphasizing integrated approaches for PCR, from traditional to digital PCR for Molecular Medicine
By Hemispherx Biopharma
Company Will Provide Updates on Alferon N Manufacturing Expansion Program and the Ampligen Chronic Fatigue Syndrome Program
By Cambridge Healthtech Institute
Highlighting the interplay between the genome-epigenome-disease
By SMi Group Ltd
SMi reports: According to Rare Disease UK, research and development in the area of rare diseases can often provide further understanding and insight into more common diseases.
By CyVek, Inc.
TGA Sciences, Inc. has collaborated with the makers of CyPlex LS, a new immunoassay platform, to make sure it addresses the needs of the pre-clinical and translational research marketplace.
SCRANTON, PA—  JUJAMA, Inc.—the leading creator of high-impact, easy-to-use event technologies supported by industry-leading customer service—announces a collaboration with Georgia Bio to provide an integrated conference registration and event...
By CyVek, Inc.
CyVek, Inc. and SBH Sciences have initiated their collaboration with the first placement of the CyPlex™ System in the United States
By Vasuda Capital Management, LLC
Vasuda Capital Management (, a Greater Boston based investment management firm has announced the launch of Vasuda Life Sciences Index.
By BPS Bioscience, Inc
BPS Bioscience, Inc. (BPS) is now offering a KEAP1:Nrf2 Inhibitor Screening Assay Kit
By Hemispherx Biopharma
Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations
By SMi Group
COPD 2014, 20th and 21st October, Holiday Inn Regents Park Hotel, London UK
By Cambridge Healthtech Institute
John R. Yates, Ph.D., Ernest W. Hahn Professor, Chemical Physiology and Molecular and Cellular Neurobiology at The Scripps Research Institute will deliver the plenary keynote address at the 14th Annual meeting (January 19-23, San Diego, California).
AstraZeneca is global pioneer in the biopharmaceutical industry specializing in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.
The investigational medicine cobimetinib being developed by Exelixis in collaboration with Roche/Genentech, combined with Zelboraf (vemurafenib); showed people with advanced melanoma lived significantly longer without their disease worsening.
Johnson & Johnson Innovation is known for its modern approach by collaborating with various life science corporations to revolutionize healthcare solutions and discover scientific breakthroughs which will benefit patients worldwide.
By Verde Media Group Inc.
VMGI Announces Significant Cost Savings in Production of Omega-3 Oils as it Prepares for Importation and Sales in the United States
By AssistRx, Inc
In July of 2010, Orlando-based technology firm AssistRx, Inc. introduced a new technology that simplifies the prescribing of specialty therapies while streamlining communications between prescribers, specialty pharmacies, patients and biotech...
Clinical data catapults FDA approval for belinostat, a new T-cell lymphoma drug that will be sold as Beleodaq from Spectrum Pharmaceuticals.
Acquisition of Seragon Pharmaceuticals will propel Genentech’s oncology R & D pipeline for an effective treatment for hormone receptor-positive breast cancer.
By AssistRx, Inc
With the recent New York legislation governing the transition of hand-written prescriptions to electronic form in 2015, both patients and physicians are critical of the efficiency and effectiveness behind the electronic exchange of data.
Johnson & Johnson Innovation, LLC focuses on accelerating early-stage innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare business

Page updated every 10 minutes

Like PRLog?
Click to Share